REGN Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

$592.28  +16.08 (2.79%)
As of 10/26/2021 15:59:57 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/01/2001
Outstanding shares:  105,106,409
Average volume:  809,122
Market cap:   $60,158,704,255
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75886F107
ISIN:        US75886F1075
Sedol:      2730190

---

Valuation   (See tab for details)

---

PE ratio:   9.76
PB ratio:   3.95
PS ratio:   4.86
Return on equity:   41.02%
Net income %:   50.11%